Mylan to pay $465 million to settle claims of shortchanging Medicaid
(‘By Ed Silverman for STAT) Mylan reached a $465 million settlement on Friday with the US Department of Justice and
Read More
Part D/Prescription Drugs
The race to create a new class of ovarian cancer drugs heats up
(By Meghana Keshavan for STAT) The race to create the next potent ovarian cancer drug is coming to a head. Ovarian
Read MoreOpinion: The Backstory on High Drug Prices
While it’s no secret that drug prices in the U.S. have been escalating at an alarming rate, one of the more
Read MoreGuidance on Moving Into Medicare from “the Marketplace”
For individuals transitioning from exchange-purchased insurance plans to Medicare, there are number of key points that need to be taken
Read MoreMedicare By The Numbers
In an article posted on www.msn.com, Selena Maranjian of the Motley Fool takes a look at nine major statistics that will help
Read MoreImproper and Illegal Drug Overcharges
In the new case of Mohr V. UnitedHealth Group, Inc., 16-cv-03352, the plaintiffs’ claims the health insurer defrauded them by
Read MoreLess than 1 percent of state prisoners with hepatitis C get treated due to drug costs
(By Ed Silverman for STAT) State prison systems are unable to lock up savings by using new hepatitis C treatments
Read MoreMylan Accused of Bilking the Taxpayers
The Centers for Medicare and Medicaid Services sent a letter to U.S. senator stating Mylan NV has been overcharging the
Read MoreLoopholes on animal antibiotics may undermine battle against superbugs
(By Helen Branswell for STAT) A new federal policy aimed at reducing the unnecessary use of antibiotics in agriculture may
Read MoreTracking Who Makes Money On A Brand-Name Drug
(By Julie Appleby for Kaiser Health News) The path of prescription drugs from the factory to the patient is complicated.
Read More